Literature DB >> 26004200

Jump from pre-mutation to pathologic expansion in C9orf72.

Zhengrui Xi1, Marka van Blitterswijk2, Ming Zhang1, Philip McGoldrick1, Jesse R McLean1, Yana Yunusova3, Erin Knock1, Danielle Moreno1, Christine Sato1, Paul M McKeever4, Raphael Schneider4, Julia Keith5, Nicolae Petrescu6, Paul Fraser1, Maria Carmela Tartaglia7, Matthew C Baker2, Neill R Graff-Radford8, Kevin B Boylan8, Dennis W Dickson2, Ian R Mackenzie9, Rosa Rademakers2, Janice Robertson4, Lorne Zinman10, Ekaterina Rogaeva11.   

Abstract

An expanded G4C2 repeat in C9orf72 represents the most common known genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). However, the lower limit for pathological expansions is unknown (the suggested cutoff is 30 repeats). It has been proposed that the expansion might have occurred only once in human history and subsequently spread throughout the population. However, our present findings support a hypothesis of multiple origins for the expansion. We report a British-Canadian family in whom a ∼70-repeat allele from the father (unaffected by ALS or FTLD at age 89 years) expanded during parent-offspring transmission and started the first generation affected by ALS (four children carry an ∼1,750-repeat allele). Epigenetic and RNA-expression analyses further discriminated the offspring's large expansions (which were methylated and associated with reduced C9orf72 expression) from the ∼70-repeat allele (which was unmethylated and associated with upregulation of C9orf72). Moreover, RNA foci were only detected in fibroblasts from offspring with large expansions, but not in the father, who has the ∼70-repeat allele. All family members with expansions were found to have an ancient known risk haplotype, although it was inherited on a unique 5-Mb genetic backbone. We conclude that small expansions (e.g., 70 repeats) might be considered "pre-mutations" to reflect their propensity to expand in the next generation. Follow-up studies might help explain the high frequency of ALS- or FTLD-affected individuals with an expansion but without a familial history (e.g., 21% among Finnish ALS subjects).
Copyright © 2015 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26004200      PMCID: PMC4457950          DOI: 10.1016/j.ajhg.2015.04.016

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  32 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

Authors:  Mariely DeJesus-Hernandez; Ian R Mackenzie; Bradley F Boeve; Adam L Boxer; Matt Baker; Nicola J Rutherford; Alexandra M Nicholson; NiCole A Finch; Heather Flynn; Jennifer Adamson; Naomi Kouri; Aleksandra Wojtas; Pheth Sengdy; Ging-Yuek R Hsiung; Anna Karydas; William W Seeley; Keith A Josephs; Giovanni Coppola; Daniel H Geschwind; Zbigniew K Wszolek; Howard Feldman; David S Knopman; Ronald C Petersen; Bruce L Miller; Dennis W Dickson; Kevin B Boylan; Neill R Graff-Radford; Rosa Rademakers
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

3.  Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration.

Authors:  Clotilde Lagier-Tourenne; Michael Baughn; Frank Rigo; Shuying Sun; Patrick Liu; Hai-Ri Li; Jie Jiang; Andrew T Watt; Seung Chun; Melanie Katz; Jinsong Qiu; Ying Sun; Shuo-Chien Ling; Qiang Zhu; Magdalini Polymenidou; Kevin Drenner; Jonathan W Artates; Melissa McAlonis-Downes; Sebastian Markmiller; Kasey R Hutt; Donald P Pizzo; Janet Cady; Matthew B Harms; Robert H Baloh; Scott R Vandenberg; Gene W Yeo; Xiang-Dong Fu; C Frank Bennett; Don W Cleveland; John Ravits
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-29       Impact factor: 11.205

4.  SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Elisa Rubino; Innocenzo Rainero; Adriano Chiò; Ekaterina Rogaeva; Daniela Galimberti; Pierpaola Fenoglio; Yakov Grinberg; Giancarlo Isaia; Andrea Calvo; Salvatore Gentile; Amalia Cecilia Bruni; Peter Henry St George-Hyslop; Elio Scarpini; Salvatore Gallone; Lorenzo Pinessi
Journal:  Neurology       Date:  2012-09-12       Impact factor: 9.910

5.  Hypermethylation of the CpG-island near the C9orf72 G₄C₂-repeat expansion in FTLD patients.

Authors:  Zhengrui Xi; Innocenzo Rainero; Elisa Rubino; Lorenzo Pinessi; Amalia C Bruni; Raffaele G Maletta; Benedetta Nacmias; Sandro Sorbi; Daniela Galimberti; Ezequiel I Surace; Yonglan Zheng; Danielle Moreno; Christine Sato; Yan Liang; Ye Zhou; Janice Robertson; Lorne Zinman; Maria Carmela Tartaglia; Peter St George-Hyslop; Ekaterina Rogaeva
Journal:  Hum Mol Genet       Date:  2014-06-06       Impact factor: 6.150

6.  C9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of Japan.

Authors:  Hiroyuki Ishiura; Yuji Takahashi; Jun Mitsui; Sohei Yoshida; Tameko Kihira; Yasumasa Kokubo; Shigeki Kuzuhara; Laura P W Ranum; Tomoko Tamaoki; Yaeko Ichikawa; Hidetoshi Date; Jun Goto; Shoji Tsuji
Journal:  Arch Neurol       Date:  2012-09

7.  The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients.

Authors:  Zhengrui Xi; Ming Zhang; Amalia C Bruni; Raffaele G Maletta; Rosanna Colao; Pietro Fratta; James M Polke; Mary G Sweeney; Ese Mudanohwo; Benedetta Nacmias; Sandro Sorbi; Maria Carmela Tartaglia; Innocenzo Rainero; Elisa Rubino; Lorenzo Pinessi; Daniela Galimberti; Ezequiel I Surace; Philip McGoldrick; Paul McKeever; Danielle Moreno; Christine Sato; Yan Liang; Julia Keith; Lorne Zinman; Janice Robertson; Ekaterina Rogaeva
Journal:  Acta Neuropathol       Date:  2015-02-26       Impact factor: 17.088

8.  Absence of expression of the FMR-1 gene in fragile X syndrome.

Authors:  M Pieretti; F P Zhang; Y H Fu; S T Warren; B A Oostra; C T Caskey; D L Nelson
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

9.  Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion.

Authors:  Zhengrui Xi; Lorne Zinman; Danielle Moreno; Jennifer Schymick; Yan Liang; Christine Sato; Yonglan Zheng; Mahdi Ghani; Samar Dib; Julia Keith; Janice Robertson; Ekaterina Rogaeva
Journal:  Am J Hum Genet       Date:  2013-05-23       Impact factor: 11.025

10.  The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder.

Authors:  Bradley N Smith; Stephen Newhouse; Aleksey Shatunov; Caroline Vance; Simon Topp; Lauren Johnson; Jack Miller; Younbok Lee; Claire Troakes; Kirsten M Scott; Ashley Jones; Ian Gray; Jamie Wright; Tibor Hortobágyi; Safa Al-Sarraj; Boris Rogelj; John Powell; Michelle Lupton; Simon Lovestone; Peter C Sapp; Markus Weber; Peter J Nestor; Helenius J Schelhaas; Anneloor Alm Ten Asbroek; Vincenzo Silani; Cinzia Gellera; Franco Taroni; Nicola Ticozzi; Leonard Van den Berg; Jan Veldink; Phillip Van Damme; Wim Robberecht; Pamela J Shaw; Janine Kirby; Hardev Pall; Karen E Morrison; Alex Morris; Jacqueline de Belleroche; J M B Vianney de Jong; Frank Baas; Peter M Andersen; John Landers; Robert H Brown; Michael E Weale; Ammar Al-Chalabi; Christopher E Shaw
Journal:  Eur J Hum Genet       Date:  2012-06-13       Impact factor: 4.246

View more
  23 in total

Review 1.  Disease Mechanisms of C9ORF72 Repeat Expansions.

Authors:  Tania F Gendron; Leonard Petrucelli
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

2.  Comprehensive genotyping of the C9orf72 hexanucleotide repeat region in 2095 ALS samples from the NINDS collection using a two-mode, long-read PCR assay.

Authors:  Eran Bram; Kamyab Javanmardi; Kimberly Nicholson; Kristen Culp; Julie R Thibert; Jon Kemppainen; Vivian Le; Annette Schlageter; Andrew Hadd; Gary J Latham
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2018-11-15       Impact factor: 4.092

Review 3.  The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease.

Authors:  Aaron R Haeusler; Christopher J Donnelly; Jeffrey D Rothstein
Journal:  Nat Rev Neurosci       Date:  2016-05-06       Impact factor: 34.870

4.  The C9ORF72 Gene, Implicated in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia, Encodes a Protein That Functions in Control of Endothelin and Glutamate Signaling.

Authors:  Vitalay Fomin; Patricia Richard; Mainul Hoque; Cynthia Li; Zhuoying Gu; Mercedes Fissore-O'Leary; Bin Tian; Carol Prives; James L Manley
Journal:  Mol Cell Biol       Date:  2018-10-29       Impact factor: 4.272

Review 5.  Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.

Authors:  Xinmei Wen; Thomas Westergard; Piera Pasinelli; Davide Trotti
Journal:  Neurosci Lett       Date:  2016-09-13       Impact factor: 3.046

Review 6.  ALS and FTD: an epigenetic perspective.

Authors:  Veronique V Belzil; Rebecca B Katzman; Leonard Petrucelli
Journal:  Acta Neuropathol       Date:  2016-06-09       Impact factor: 17.088

Review 7.  C9orf72-mediated ALS and FTD: multiple pathways to disease.

Authors:  Rubika Balendra; Adrian M Isaacs
Journal:  Nat Rev Neurol       Date:  2018-09       Impact factor: 42.937

Review 8.  Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Jared S Katzeff; Fiona Bright; Katherine Phan; Jillian J Kril; Lars M Ittner; Michael Kassiou; John R Hodges; Olivier Piguet; Matthew C Kiernan; Glenda M Halliday; Woojin Scott Kim
Journal:  Brain       Date:  2022-06-03       Impact factor: 15.255

9.  Marked Differences in C9orf72 Methylation Status and Isoform Expression between C9/ALS Human Embryonic and Induced Pluripotent Stem Cells.

Authors:  Yaara Cohen-Hadad; Gheona Altarescu; Talia Eldar-Geva; Ephrat Levi-Lahad; Ming Zhang; Ekaterina Rogaeva; Marc Gotkine; Osnat Bartok; Reut Ashwal-Fluss; Sebastian Kadener; Silvina Epsztejn-Litman; Rachel Eiges
Journal:  Stem Cell Reports       Date:  2016-10-20       Impact factor: 7.765

10.  Improved PCR based methods for detecting C9orf72 hexanucleotide repeat expansions.

Authors:  Elaine M Cleary; Suvankar Pal; Tara Azam; David J Moore; Robert Swingler; George Gorrie; Laura Stephenson; Shuna Colville; Siddharthan Chandran; Mary Porteous; Jon P Warner
Journal:  Mol Cell Probes       Date:  2016-06-07       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.